Lithium regulation of aldolase A expression in the rat frontal cortex: Identification by differential display

Biological Psychiatry

Volumn 48, Issue 1, 2000, Pages 58-64

  Hua, Len V ^a,b   Green, Marty ^a   Warsh, Jerry J ^a,b,c   Li, Peter P ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aldolase A; Bipolar disorder; Carbamazepine; Differential display; Gene expression; Lithium; mRNA

Indexed keywords

CARBAMAZEPINE; COMPLEMENTARY DNA; DNA FRAGMENT; FRUCTOSE BISPHOSPHATE ALDOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE ISOENZYME; LITHIUM; MESSENGER RNA; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DISPLAY POLYMERASE CHAIN REACTION; DISPLAY SYSTEM; DNA SEQUENCE; DRUG BLOOD LEVEL; DRUG MECHANISM; FRONTAL CORTEX; GENE CONTROL; GENE EXPRESSION; MALE; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FRONTAL LOBE; FRUCTOSE-BISPHOSPHATE ALDOLASE; GENE EXPRESSION REGULATION; LITHIUM; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0034237724     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00824-6     Document Type: Article

References (33)

1. Agam G., Levine J. Glycogen synthase kinase-3 - a new target for lithium's effects in bipolar patient? Hum Psychopharmacol Clin Exp. 13:1998;463-465.
2. Asghari V., Wang J.F., Reiach J.S., Young L.T. Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells. Mol Brain Res. 58:1998;95-102.
3. 3-binding domains as determined by site-directed mutagenesis. Biochem J. 341:1999;805-812.
4. Calabrese JR, Woyshville MJ, Rapport DJ (1994): Clinical efficacy of valproate. In: Joffe RT, Calabrese JR, editors. Anticonvulsants in Mood Disorders. New York: Marcel Dekker, 131-146.
5. i-protein α-subunit in rat cerebral cortex. Proc Natl Acad Sci U S A. 88:1991;10634-10637.
6. Dubovsky S.L., Murphy J., Christiano J., Lee C. The calcium second messenger system in bipolar disorders Data supporting new research directions . J Neuropsychiatry Clin Neurosci. 4:1992;3-14.
7. 2 receptor mRNA in the rat striatum and nucleus accumbens. Acta Neurobiol Exp. 56:1996;29-34.
8. Emamghoreishi M., Schlichter L., Li P.P., Parikh S., Sen J., Kamble A., et al. High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry. 154:1997;976-982.
9. Feinstein D.L. Potentiation of astroglial nitric oxide synthase type-2 expression by lithium chloride. J Neurochem. 71:1998;883-886.
10. Hudson C., Young L.T., Li P.P., Warsh J.J. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse. 13:1993;278-293.
11. Hyman S.E., Nestler E.J. Initiation and adaptation A paradigm for understanding psychotropic drug action . Am J Psychiatry. 153:1996;151-162.
12. Joh K., Mukai T., Yatsuki H., Hori K. Rat aldolase A messenger RNA The nucleotide sequence and multiple mRNA species with different 5′-terminal regions . Gene. 39:1985;17-24.
13. Jope R.S. Anti-bipolar therapy Mechanism of action of lithium . Mol Psychiatry. 4:1999;117-128.
14. Kao A.W., Noda Y., Johnson J.H., Pessin J.E., Saltiel A.R. Aldolase mediates the association of F-actin with the insulin-responsive glucose transporter GLUT4. J Biol Chem. 274:1999;17742-17747.
15. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A. 93:1996;8455-8459.
16. Koppitz B., Vogel F., Mayr G.W. Mammalian aldolases are isomer-selective high affinity inositol polyphosphate binders. Eur J Biochem. 161:1986;421-433.
17. Kusakabe T, Kiyohisa M, Hori K (1997): Mode of interactions of human aldolase isosymes with cytoskeletons. Arch Biochem Biophys 344184-344193.
18. Li PP, Andreopoulos S, Warsh JJ (2000): Signal transduction abnormalities in bipolar affective disorder. In: Reith MEA, editor. Cerebral Signal Transduction: From First to Fourth Messengers. Totowa, NJ: Humana, 283-309.
19. Li P.P., Tam Y.K., Young L.T., Warsh J.J. Lithium decreases Gs, Gi-1 and Gi-2 α-subunit mRNA levels in rat cortex. Eur J Pharmacol Mol Pharmacol. 206:1991;165-166.
20. Li P.P., Young L.T., Tam Y.K., Sibony D., Warsh J.J. Effects of chronic lithium and carbamazepine treatment of G-protein subunit expression in rat cerebral cortex. Biol Psychiatry. 34:1993;162-170.
21. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971.
22. Manji H.K., Potter W.Z., Lenox R.H. Signal transduction pathways Molecular targets for lithium's actions . Arch Gen Psychiatry. 52:1995;531-543.
23. Marcus F., Hosey M.M. Purification and properties of liver fructose 1,6-bisphosphatase from C57BL/KsJ normal and diabetic mice. J Biol Chem. 255:1980;2481-2486.
24. Meltzer H.Y. Creatine kinase and aldolase in serum Abnormality common to acute psychoses . Science. 159:1968;1368-1370.
25. Miller J.C., Mathe A.A. Basal and stimulated C-fos mRNA expression in the rat brain Effect of chronic dietary lithium . Neuropsychopharmacology. 16:1997;408-418.
26. Ozaki N., Chuang D.M. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J Neurochem. 69:1997;2336-2344.
27. Ronai Z., Robinson R., Rutberg S., Lazarus P., Sardana M. Aldolase-DNA interactions in a SEWA cell system. Biochim Biophys Acta. 1130:1992;20-28.
28. Sivam S.P., Krause J.E., Takeuchi K., Li S., McGinty J.F., Hong J.S. Lithum increases rat striatal beta- and gamma-preprotachykinin messenger RNAs. J Pharmacol Exp Ther. 248:1989;1297-1301.
29. Sivam S.P., Takeuchi K., Li S., Douglass J., Civelli O., Calvetta L., et al. Lithium increase dynorphin A (1-8) and prodynorphin mRNA levels in the basal ganglia of rats. Mol Brain Res. 3:1988;155-164.
30. Volker K.W., Knull H.R. A glycolytic enzyme binding domain on tubulin. Arch Biochem Biophys. 338:1997;237-243.
31. Wang J.F., Asghari V., Rockel C., Young L.T. Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells. Neuroscience. 91:1999;771-776.
32. Wang J.F., Young L.T. Differential display PCR reveals increased expression of 2′3′-cyclic nucleotide 3′-phosphodiesterase by lithium. FEBS Lett. 386:1996;225-229.
33. Yuan P.X., Chen G., Huang L.D., Manji H.K. Lithium stimulates gene expression through the AP-1 transcription factor pathway. Mol Brain Res. 58:1998;225-230.